Medi Pedi NYC Aesthetic & Therapeutic Foot Care – Trademark Portfolio
Entity Type: 03
Medi Pedi NYC Aesthetic & Therapeutic Foot Care holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include MEDI PEDI NYC AESTHETICS & THERAPEUTIC FOOT CARE BY: MARCELA CORREA. The owner is based in New York, NY.
20 Park Avenue
New York, NY 10016
Showing of trademarks Trademarks
Trademark Classifications
Medi Pedi NYC Aesthetic & Therapeutic Foot Care's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Medi Pedi NYC Aesthetic & Therapeutic Foot Care have?
Medi Pedi NYC Aesthetic & Therapeutic Foot Care has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Medi Pedi NYC Aesthetic & Therapeutic Foot Care file in?
Medi Pedi NYC Aesthetic & Therapeutic Foot Care files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Medi Pedi NYC Aesthetic & Therapeutic Foot Care's most well-known trademarks?
Medi Pedi NYC Aesthetic & Therapeutic Foot Care's registered trademark portfolio includes well-known marks such as MEDI PEDI NYC AESTHETICS & THERAPEUTIC FOOT CARE BY: MARCELA CORREA. These are among 2 currently registered trademarks in the portfolio.
What is Medi Pedi NYC Aesthetic & Therapeutic Foot Care's trademark registration success rate?
Medi Pedi NYC Aesthetic & Therapeutic Foot Care has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.